/Eli%20Lilly%20and%20Co_%20by%20Sergio%20Photone%20via%20Shutterstock.jpg)
With a market cap of $694.9 billion, Eli Lilly and Company (LLY) is a leading global pharmaceutical company headquartered in Indianapolis, Indiana. Founded in 1876, it is renowned for developing innovative medicines in areas such as diabetes, oncology, immunology, neuroscience, and obesity management.
Companies valued over $200 billion are generally described as “mega-cap” stocks, and Eli Lilly fits right into that category. The company has a strong research and development focus, investing heavily in next-generation biologics, oncology therapies, and treatments for neurodegenerative diseases such as Alzheimer’s. It is also expanding in immunology and rare diseases through acquisitions and strategic collaborations.
